Twelve regulatory authorities from around the world will be among attendees discussing the opportunities provided by collaborating to achieve harmonization in regulation at the Latin American Regulatory Conference (LARC) 2014.

Global regulators, industry professionals and academia will gather at the event in Miami, Florida from May 14 to 15 to discuss the current regulatory landscape, future research and drug development in Latin America.

The main theme of this year’s conference will be “Growing Global Opportunities via Pharma-Co-Vergence in our Region”, highlighting the benefits of achieving pharmaceutical regulatory convergence through stakeholders’ collaboration.

Program Committee member Maria Guazzaroni Jacobs, PhD, Director of Quality and Regulatory Policy (QRP) for Pfizer Inc., US, said: “Attending LARC allows you to update your knowledge on the regulatory landscape in Latin America and is an opportunity to interact with regulatory agency officials and experts in the region.”

High profile presenters will include keynote speaker Ricardo Walter Rüttimann, Director of the Vaccines Division at Fighting Infectious Diseases in Emergent Countries (FIDEC-FUNCEI) in the US.

The meeting will also feature expert regulatory speakers including Patricia Aprea, MD, Head of the Biologics Products Department at ANMAT, who will give the Argentinian perspective on biotherapeutics and biosimilar products; Francisco Garcia Zetina, IQ, Director for COFEPRIS, who will give the Mexican perspective during the same session; and Guisela Zurich, QF, Head of ANAMED, who will give the Chilean perspective on the potential benefits and challenges of Multi-regional Clinical Trials (MRCTs).

Featured topics include:

• Regulatory Landscape and Regulatory Convergence Framework: Red PARF/ VII PANDRH Discussions
• New Regulatory Approaches and Initiatives
• Multi-regional Clinical Trials (MRCTs)
• Drug Safety, Marketing Surveillance, and Quality Control Monitoring
• Health Systems and Security of the Supply Chain: Traceability and Counterfeit Medicines
• Biologics and Biosimilars Regulations: Industry and Regulatory Agency Perspectives
• Emerging Topics

For more information or to register visit www.diahome.org/LARC2014

View a video interview with a previous attendee.

Contact: Alejandro Bermudez
Project Coordinator, Latin America
+1.202.601.9061
Alejandro.Bermudez@dialatinamerica.org

 

###